John Penn
-
Insights on diabetic retinopathy
A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report. Read MoreJan 23, 2020
-
New targets for diabetic retinopathy
Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults. Read MoreJan 21, 2016
-
VUMC’s Penn named president-elect of eye research society
John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER). Read MoreFeb 12, 2015
-
Meranze, Penn named to new Faculty Affairs roles
Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs. Read MoreJul 10, 2014
-
Penn named to vision group’s scientific advisory panel
John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel. Read MoreOct 31, 2013
-
Penn seeks new look at eye disorder
John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated. Read MoreMar 7, 2013